Preparation and in vivo/in vitro characterization of Ticagrelor PLGA sustained-release microspheres for injection

References

• Dlfox B. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events[J]. Digest World Core Med J(Cardiology). 2006;142(2):1706–1717.
   Google Scholar
• Huber K, Hamad B, Kirkpatrick P. Ticagrelor[J]. Nat Rev Drug Discov. 2011;10(4):255–256.
   PubMed Web of Science ®Google Scholar
• Li W, Han W, Zhao NA, et al. A novel embolic microspheres with micro nano binary progressive structure for transarterial chemoembolization applications - ScienceDirect[J]. Eur J Pharm Sci. 2020;153:105496.
   PubMed Web of Science ®Google Scholar
• Li T, Chandrashekar A, Beig A, et al. Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres[J]. Eur J Pharm Biopharm. 2021;158:401–409.
   PubMed Web of Science ®Google Scholar
• Cz A, Liang YB, Feng WC, et al. Quality by design thinking in the development of long-acting injectable PLGA/PLA-based microspheres for peptide and protein drug delivery[J]. Int J Pharm. 2020;585:119441.
   PubMedGoogle Scholar
• B B P A, C M A C, D K B, et al. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres[J]. J Control Release. 2004;96(3):437–448.
   PubMed Web of Science ®Google Scholar
• Chu DF, Fu XQ, Liu WH, et al. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs[J]. Int J Pharm. 2006;325(1–2):116–123.
   PubMed Web of Science ®Google Scholar
• Vlugt-Wensink KDF, De Vrueh R, et al. Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation[J]. Pharm Res. 2007;24(12):2239–2248.
   PubMed Web of Science ®Google Scholar
• Yanyun H. Jingjing, et al. SN-38-Loaded PLGA microspheres injected intratumorally for cancer: preparation, characterization and evaluation - ScienceDirect[J]. J Drug Delivery Sci Technol. 2019;53:101178.
   Web of Science ®Google Scholar
• Myha B, Ytha C, Cjwb D, et al. Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly[lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection[J]. Colloids Surf B Biointerfaces. 2020;190:110937.
   PubMed Web of Science ®Google Scholar
• Ma C, Fu H, Huang Z, et al. Accelerated dissolution method to facilitate in vitro evaluation of risperidone-containing microspheres[J]. Dissolution Technol. 2019;26(2):48–55.
   Web of Science ®Google Scholar
• Sun Y, Long D. Preparation, characterization and in vitro/in vivo evaluation of lovastatin-loaded PLGA microspheres by local administration for femoral head necrosis[J]. Drug Des Devel Ther. 2021;15:601–610.
   PubMed Web of Science ®Google Scholar
• Hadi N, Braihi A, Mohammed SK. Effect of flow behavior on the production of PVA/dextrin microspheres. [J].j Controlled release. 2018;7:669–675.
   Google Scholar
• Hui ZA, Lzh B, Jap A, et al. Microfluidic fabrication of inhalable large porous microspheres loaded with H 2 S-releasing aspirin derivative for pulmonary arterial hypertension therapy[J]. J Control Release. 2021;329:286–298.
   PubMed Web of Science ®Google Scholar
• Jyothi N, Prasanna M, Prabha S, et al. Microencapsulation techniques, factors influencing encapsulation efficiency: a review[J]. J Microencapsul. 2010;27(3):187–197.
   PubMed Web of Science ®Google Scholar
• Al-Maaieh A, Flanagan DR. New drug salt formation in biodegradable microspheres[J]. Int J Pharm. 2005;303(1–2):153–159.
   PubMedGoogle Scholar
• Rawat A, Burgess DJ. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics[J]. Int J Pharm. 2010;394(1–2):99–105.
   PubMed Web of Science ®Google Scholar
• Rouse JJ, Mohamed F, Walle C. Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA[J]. Int J Pharm. 2007;339(1–2):112–120.
   PubMedGoogle Scholar
• Mauduit J, Bukh. Ordinary, with rt. M. Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of gentamycin sulfate in films prepared from high and low molecular weight poly (DL-lactic acids)[J]. J Control Release. 1993;25(1–2):43–49.
   Web of Science ®Google Scholar
• Liggins RT, Burt HM. Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers[J]. Int J Pharm. 2001;222(1):19–33.
   PubMedGoogle Scholar
• Rawat A, Burgess DJ. Effect of physical ageing on the performance of dexamethasone loaded PLGA microspheres[J]. Int J Pharm. 2011;415(1–2):164–168.
   PubMedGoogle Scholar
• Tamani F, Bassand C, Hamoudi MC, et al. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: monolithic dispersions studied at lower temperatures[J]. Int J Pharm. 2021;596:120220.
   PubMedGoogle Scholar
• Vasiliki P, et al. On the use of the Weibull function for the discernment of drug release mechanisms.[J]. Int J Pharm. 2006;309(1–2):44–50.
   PubMedGoogle Scholar
• Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles[J]. Int J Pharm. 2008;364(2):298–327.
   PubMed Web of Science ®Google Scholar
• Wang T, Xue P, Wang A, et al. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: the effect of polymer blends[J]. Eur J Pharm Sci. 2019;138:104990.
   PubMed Web of Science ®Google Scholar
• O’Hara T, Hayes S, Davis J, et al. In vivo–in vitro (IVIVC) modeling incorporating a convolution step[J]. J Pharmacokinet Pharmacodyn. 2001;28(3):277–298.
   PubMed Web of Science ®Google Scholar
• Andhariya JV, Jog R, Shen J, et al. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres[J]. J Control Release. 2019;308:1–13.
   PubMed Web of Science ®Google Scholar